Introduction
Mast cells originate in bone marrow from mast cellcommitted precursors. They enter the circulation as progenitors which colonize the peripheral tissues and mature into cells with a characteristic phenotype. Thereafter, mature mast cells are enrolled in various immunological reactions such as allergy and inflammation. In healthy rats, mast cells are abundantly present in the mesentery, while the thyroid gland and a number of other organs harbor a moderate number of these cells [1] . Alongside mast cells in the peritoneal cavity and the skin, mast cells of the thyroid gland are classified as connective-tissue mast cells as opposed to mucosal mast cells which reside in the intestinal mucosa. Thyroid mast cells are localized in the connective tissue stroma usually closely positioned to blood vessels or thyroid follicles. Biologically active molecules synthesized in mast cells have a potency to affect neighboring parenchymal cells of the thyroid gland and the thyroid blood flow. Namely, mast cell-derived serotonin is involved in thyroid hormone production and secretion by influencing follicular cells in a paracrine manner [2] . Chymase, a neutral protease originating from mast cells, is able to modify the morphology of thyroid follicular cells in culture inducing cellular retraction and appearance of cytoplasmic extensions with redistribution of cellular cytoskeletal components actin and tubulin [3] . Mast cells are also involved in the regulation of thyroid vasculature via a potent vasoactive mediator histamine which increases glandular blood flow and capillary permeability [4] .
The circadian rhythm of mast cell number within the thyroid correspond to the circadian rhythm of the gland itself. In the morning hours when the thyroid activity is low, the number of mast cells is decreased, but thereafter gradually increases during the day, being the highest in the evening when the glandular activity is highest too [5] . The number of mast cells also changes in certain thyroid pathologies such as the experimentally-induced goitre which is accompanied by the proliferation of mast cells [6] . The regenerative site of subacute thyroiditis involving both folliculogenesis and angiogenesis is characterized by the increased number of mast cells [7] . According to the latest literature data, mast cells infiltrate thyroid papillary carcinoma and promote the proliferation of tumor cells [8] .
Atrazine (IUPAC: 6-chloro-N 2 -ethyl-N 4 -isopropyl-1,3,5-triazine-2,4-diamine) is a triazine herbicide widely used in the production of corn, sugar cane and sorghum. It is commonly used in non-EU countries and is one of the most used pesticides in the US [9] . The increasing interest of biological effects of atrazine is related to the detection of this compound in groundwater, surface water and in drinking water [10] . To date, experimental studies had provided sufficient evidence to classify atrazine as an endocrine disruptor and reproductive toxicant [11] [12] [13] . Experimental studies on atrazine effects on the thyroid gland demonstrated a significant increase in the serum T3 level in juvenile/ peripubertal male rats treated with 200 mg/kg body weight (bw) of atrazine while the levels of T4 and TSH remained unaffected by the treatment [14] . Our previous study demonstrated a significant decrease in mast cell number in the thyroid gland of juvenile/peripubertal male rats exposed to atrazine at a 200 mg/kg bw dose, while the exposure to a ten times lower dose (20 mg/kg bw) had the same effect, but was not statistically significant when compared to the control [15] .
Considering previously reported data on mast cell importance for thyroid physiology and the results of our previous studies on atrazine effects [15] we performed an investigation in order to characterize the influence of atrazine on thyroid mast cells and to provide data on a possible dose-dependent and age-dependent differences in mast cell sensitivity to the treatment. In this respect, the mast cell morphological features were determined on histological evaluation, while the number and volume of these cells were quantified using stereological methods.
Experimental Procedures

Experimental animals
The experiment was performed on male Wistar rats during two different periods of ontogeny. The study included 21 juvenile rats from their 23 rd postnatal day (PND) and 21 adult rats from the 92 nd PND at the beginning of the study. During the experiment, animals were housed under a constant temperature of 22±1ºC and subjected to a controlled photoperiod (14 h light, 10 h dark). All animals had free access to the standard granulated food and drinking water. A day prior to the beginning of the experimental procedure, animals were weighted and randomly assigned to adequate agedependent experimental group.
All procedures were performed strictly according to the generally accepted international rules and regulations on animal experiments. The investigation was carried out with the permission of the Ethical Committee on Animal Experiments of the University in Novi Sad, Serbia, and in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the US National Institutes of Health.
Experimental design
The two main categories of animals in respect to their ages were randomly divided into 3 experimental groups consisting of 7 animals each. Experimental groups of juvenile and adult rats were, respectively: the control group, the group treated with 50 mg atrazine/kg bw and the group treated with 200 mg atrazine/kg bw. In total, the study consisted of 6 experimental groups in correspondence to their ages and the treatments. Animals were treated per orally, via gavage with adequate atrazine solutions during 28 days starting with PND 23 for juvenile and PND 92 for adult rats, respectively. Atrazine solution contained 97% of technical atrazine (a kind gift from professor Sanja Lazic, Institute for Environmental and Plant Protection, Faculty of Agriculture, University of Novi Sad, Serbia) dissolved in olive oil. The control groups were given olive oil only. The treatments were administered daily between 08.00 and 09.00 h. Atrazine doses were selected based on literature data on its investigated biological effects [14] .
Tissue processing
Animals were sacrificed 24 hrs following the last atrazine treatment. Subsequently, the thyroid glands were sampled, fixed in Bouin fixative, routinely processed for paraffin embedding and afterwards cut into 5 µm-thick sections using a rotary microtome. Sections were further stained according to the histochemical staining method with toluidine blue (Carlo Erba, Milano, Italy) for morphological analysis and stereologybased quantitative estimation of the thyroid mast cell population. Toluidine blue metachromatically stains the proteoglycan molecules stored in cytoplasmic secretory granules of mast cells enabling thus a clear visualization of these cells within the thyroid as opposed to paledyed other stromal as well as parenchymal glandular components.
Stereological analysis
Paraffin sections of the thyroid gland were analyzed by a point-counting method using the multipurpose stereological M42 test system [16] placed in the ocular of a light microscope. Using 10x ocular and 40x objective magnification 100 fields of vision were analyzed per animal. The numerical (Nv; mm -3 ) and volume densities (Vv; mm 3 /mm 3 ) [16] of the mast cells were determined.
Statistical analysis
The analysis of variance (one-way ANOVA) with the Bonferroni post-hoc test was used for the statistical analysis of the numerical data within each of the age group. The Student's t-test was used only to check for statistically significant difference in the number of mast cells between the control group of the juvenile/ peripubertal rats and the control group of the adults. The p values less than 0.05 were considered significant.
Results
Histological evaluation
Histological Degranulation intensity was particularly increased in both age groups treated with the higher dose of atrazine ( Figure 1F and Figure 2F ).
Stereological analysis
In juvenile/peripubertal rats the toluidine blue-positive mast cells demonstrated a statistically significant decrease in cell volume density (Vvm) in the group treated with the lower atrazine dose as compared to the control (P<0.001) ( Table 1) . On the other hand, there were no statistically significant changes in numerical density of mast cells (Nvm) in atrazine treated groups compared to the control (Table 1) . Stereological analysis of thyroid mast cells in the adult animals showed a statistically significant decrease of the numerical density of mast cells (Nvm) in the group treated with the higher atrazine dose compared to the control and also compared to the lower dose of atrazine (P<0.05 and P<0.01, respectively) ( Table 2) . Neither of the two atrazine doses had a significant effect on the volume density (Vvm) of mast cells compared to the control.
Regarding mast cells in the control groups, the numerical density of mast cells was found higher in young rats compared to adults, but the difference was not statistically significant (P>0.05) ( Table 1 and 2). 
Discussion
Early studies on thyroid mast cells indicated that their number is regulated by pituitary TSH. Single injection of TSH was able to produce depletion of serotonin content from the perivascular mast cells in the thyroid gland [17] . Increased levels of plasma TSH in propylthiouracil treated rats increased the number of mast cells in the thyroid and evoked a release of histamine and serotonin from cytoplasmic storages [18] . The TSH also promoted histamine and serotonin release from mast cells in the mouse thyroid [19] .
The present study revealed a sensitivity of mast cells to atrazine treatment demonstrated through cell degranulation as a common histological finding at both investigated doses of atrazine and in both age groups. Additionally, a decreased volume density of mast cells in young rats treated with a higher atrazine dose recorded at stereological analysis point to an increased release of metachromatic material from mast cells and to mast cell degranulation. Our results are in accordance with the literature data that have provided evidence about atrazine-induced mast cell degranulation under certain experimental conditions [20] . In vitro studies conducted on the mast cell line RBL-2H3 and the peritoneal mast cells demonstrated mast cell degranulation as measured through granuleassociated β-hexosaminidase release [20] . This effect was found to be related to atrazine-induced activation of membrane-associated receptor G q/11 which is further mediated by phospholipase C and calcium mobilization from intracellular stores [20] . Comparing the response of the two cell cultures to atrazine exposure, the study revealed that peritoneal mast cells were more sensitive to the treatment than RBL-2H3 cells as judged by the intensity of cell degranulation. Regarding thyroid mast cells, a possible TSH-induced degranulation and the degranulation induced through a G q/11 receptor are two different concepts, since a Gs-type TSH receptor activation consequently activates adenylate cyclase. Having in mind another Gs-coupled receptor identified as a putative atrazine receptor, the growth hormonereleasing hormone receptor [21] , along with the abovementioned differences in sensitivity of mast cells originating from different organs and, finally, the TSH regulatory role towards thyroid mast cells, it seems likely that the atrazine effects on mast cells in the thyroid are mediated through a Gs type receptor. In favor of this hypothesis is a well-known potent effect of TSH on the depletion of mast cell granule content as well as the TSH regulation of mast cell number within the thyroid. Which of the receptor type and corresponding signaling pathway is involved in mediating atrazine effects on thyroid mast cells is, however, still to be determined in future studies.
A prominent histological finding of numerous degranulated mast cells in all atrazine treated groups (both ages, both doses) was only partially supported with the results of the statistical analysis. Although the numerical data also point to cell degranulation as evidenced by the decreased volume density of mast cells in all treated groups compared to the corresponding controls, only the decreased volume density in young rats treated with a higher dose of atrazine (200 mg/kg bw) was statistically significant when compared to the control. Certainly, the use of immune markers against mast cell mediators would have provided better understanding of mast cell activity from a histological standpoint, however, the release of metachromatic material itself indicate the mast cell active involvement in thyroid response to atrazine treatments. Regarding the calculated numerical density of mast cells, our results demonstrated a moderate increase of the cell number in young rats, while opposite effects were found in the adults characterized by a moderate increase in a lower dose atrazine group and a significant decrease in a higher dose group as compared to the control. In spite of this decrease in number of cells in the later group of adults (200 mg/kg bw) the decrease in the volume density of mast cells is a concomitant morphological reaction aiming to maintain the net physiological action of mast cells within the thyroid. In young rats exposed to a higher dose of atrazine the release of preformed mediators from mast cells, histamine and serotonin, can be presumed since it has been demonstrated that they are co-stored and jointly released with the metachromatically stained proteoglycan molecules [22] . Consequently, these mediators might affect the thyroid vascular bed leading to increased blood flow and capillary permeability, but might also increase thyroid hormone synthesis and secretion. According to the numerical data, these physiological effects in all other atrazine treated groups would be somewhat less in magnitude. Further, the results of the quantification analysis showed a decrease of mast cell numerical density in the adult control as compared to the control group in young rats confirming thereby earlier findings on decrease in thyroid mast cell number with age [23] .
Contrary to our results, a reduced degranulation of mast cells in the thyroid gland situated perifollicularly was found after atrazine treatments, but no effect on the intensity of degranulation was detected for the stromal mast cells [24] . Calculations of the volume density of thyroid mast cells after atrazine treatments of peripubertal rats at doses of 20 mg/kg bw or 200 mg/kg bw showed no significant differences compared to the control, while the numerical density of mast cells was found significantly lowered by the higher dose of atrazine [15] . Certain experimental data point to annual variations in the serum levels of TSH with the lowest value in the spring [25] , which might provide a possible explanation for the discrepancy in the numerical density of thyroid mast cells in rats of the same age treated with 200 mg of atrazine/kg bw in our previous study carried out during spring and the present investigation performed in winter.
Literature data on experimental studies indicate that oxidative stress might activate mast cells [26, 27] . Reactive oxigen species (ROS) generated during oxidative stress increase the rate of lipid peroxidation leading to damage of the membrane lipids. ROS generated in mitochondria are efficient in activating nonIgE sensitized mast cells thereby enhancing histamine and serotonin release [28] . According to the latest studies, formation of free radicals could be a cause of lipid peroxidation and intracellular increase in calcium ions while ion pumps e.g. calcium ATP-ase could be completely inhibited by atrazine-induced oxidation of SH groups in proteins [29] . The result of these events is calcium accumulation in the cell, which can lead to mast cell degranulation. Investigation of high-dose atrazineinduced effects (300 mg/kg bw) at the molecular level showed a decrease in total lipid, cholesterol and phospholipid content in the cell membrane, which can be attributed to an increased lipid peroxidation [30] . These results point to the induction of oxidative stress in cells by atrazine exposure, an effect that has already been shown by various pesticides [31] .
Finally, it should be stressed that a mast cell involvement in certain thyroid pathologies has been demonstrated as a concomitant event to alterations of the glandular parenchyma. The release of mast cell granule content, as evidenced through decreased mast cell diameter, has been observed in rats with experimentally induced goiter [6] . Tryptase-positive mast cells were identified in differentiated papillary thyroid carcinoma in humans contrary to normal tissue samples characterized by their absence [8] . Furthermore, mast cells promoted histamine-and cytokine-mediated proliferation of thyroid cancer cells, induced their migration and inhibited apoptosis of these cells in the in vitro conditions [8] . An association has recently been reported between thyroid cancer and atrazine use in pesticide applicators in the highest quartile of atrazine use [32] . According to our current results and the literature data on atrazine, the mast cell involvement in the state of thyroid pathology parallel to atrazine exposure could be assumed, but yet to be confirmed. The elucidation of the exact functional role of atrazine-activated mast cells in the thyroid disease therefore, requires further investigation. The future studies would, hopefully, provide sufficient information of the mast cell-derived mediators involved in response to atrazine exposure during the existing thyroid pathology and, consequently, to which extent mast cells aggravate the disease.
In conclusion, the results of the present study demonstrate an increase of thyroid mast cell degranulation in peripubertal and adult rats treated with atrazine at both doses (50 or 200 mg/kg bw), which was particularly emphasized in young animals. The degree of cell degranulation was dose-dependent. The number of mast cells, expressed through the cell numerical density, was significantly lowered in adults at a higher dose of applied atrazine. Such mast cell status within the thyroid is expected to affect glandular microvasculature and follicular cells leading to increased thyroid hormone production, secretion, blood flow and capillary permeability. The present results also suggest that the induction of mast cell activation could be agedependent and, finally, according to our previous and present data the thyroid mast cell response to atrazine, demonstrate annual variations.
